AptarGroup, Inc.
General ticker "ATR" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $9.7B (TTM average)
AptarGroup, Inc. does not follow the US Stock Market performance with the rate: -13.1%.
Estimated limits based on current volatility of 1.3%: low 123.81$, high 126.98$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-10-23, amount 0.48$ (Y1.54%)
- Total employees count: 13500 (-2.2%) as of 2024
- North America accounted for 32.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Labor/talent shortage/retention, Geopolitical risks, Product development risks, Market risk
- Current price 17.0% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [140.02$, 186.02$]
- 2025-12-31 to 2026-12-31 estimated range: [150.19$, 198.88$]
Financial Metrics affecting the ATR estimates:
- Negative: with PPE of 28.1 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 13.86
- Positive: 42.53 < Shareholder equity ratio, % of 55.77 <= 64.17
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.78 > 6.04
- Positive: Inventory ratio change, % of -1.50 <= -0.76
- Negative: Industry inventory ratio change (median), % of 1.40 > 0.28
- Positive: Interest expense per share per price, % of 0.42 <= 0.74
Short-term ATR quotes
Long-term ATR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3,322.25MM | $3,487.45MM | $3,582.89MM |
| Operating Expenses | $2,942.98MM | $3,083.43MM | $3,086.39MM |
| Operating Income | $379.27MM | $404.02MM | $496.50MM |
| Non-Operating Income | $-44.57MM | $-29.19MM | $-26.73MM |
| Interest Expense | $40.83MM | $40.42MM | $43.90MM |
| Income(Loss) | $334.70MM | $374.82MM | $469.76MM |
| Taxes | $95.15MM | $90.65MM | $95.59MM |
| Profit(Loss)* | $239.29MM | $284.49MM | $374.54MM |
| Stockholders Equity | $2,053.93MM | $2,306.82MM | $2,471.89MM |
| Inventory | $486.81MM | $513.05MM | $461.81MM |
| Assets | $4,203.46MM | $4,451.89MM | $4,432.28MM |
| Operating Cash Flow | $478.62MM | $575.24MM | $643.41MM |
| Capital expenditure | $315.62MM | $318.40MM | $294.19MM |
| Investing Cash Flow | $-295.64MM | $-324.46MM | $-396.72MM |
| Financing Cash Flow | $-162.10MM | $-171.55MM | $-225.34MM |
| Earnings Per Share** | $3.66 | $4.34 | $5.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.